740 related articles for article (PubMed ID: 33449302)
1. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
[TBL] [Abstract][Full Text] [Related]
3. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
Yanaba K
J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC
Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
[TBL] [Abstract][Full Text] [Related]
5. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
Antic M; Distler JH; Distler O
Curr Opin Pharmacol; 2013 Jun; 13(3):455-62. PubMed ID: 23747024
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
Distler O; Cozzio A
Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
[TBL] [Abstract][Full Text] [Related]
7. Systemic and localized scleroderma in children: current and future treatment options.
Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
[TBL] [Abstract][Full Text] [Related]
8. The contemporary management of systemic sclerosis.
Eldoma M; Pope J
Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.
Saketkoo LA; Frech T; Varjú C; Domsic R; Farrell J; Gordon JK; Mihai C; Sandorfi N; Shapiro L; Poole J; Volkmann ER; Lammi M; McAnally K; Alexanderson H; Pettersson H; Hant F; Kuwana M; Shah AA; Smith V; Hsu V; Kowal-Bielecka O; Assassi S; Cutolo M; Kayser C; Shanmugam VK; Vonk MC; Fligelstone K; Baldwin N; Connolly K; Ronnow A; Toth B; Suave M; Farrington S; Bernstein EJ; Crofford LJ; Czirják L; Jensen K; Hinchclif M; Hudson M; Lammi MR; Mansour J; Morgan ND; Mendoza F; Nikpour M; Pauling J; Riemekasten G; Russell AM; Scholand MB; Seigart E; Rodriguez-Reyna TS; Hummers L; Walker U; Steen V
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101707. PubMed ID: 34538573
[TBL] [Abstract][Full Text] [Related]
10. Treatment of systemic sclerosis.
Thoreau B; Chaigne B; Renaud A; Mouthon L
Presse Med; 2021 Apr; 50(1):104088. PubMed ID: 34718109
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
12. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
13. [Scleroderma].
Distler O; Gay S
Internist (Berl); 2010 Jan; 51(1):30-8. PubMed ID: 20033389
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the diagnosis and treatment of systemic sclerosis.
Kowal-Bielecka O; Bielecki M; Kowal K
Pol Arch Med Wewn; 2013; 123(1-2):51-8. PubMed ID: 23344666
[TBL] [Abstract][Full Text] [Related]
15. Use of Extracorporeal Photopheresis in Scleroderma: A Review.
Du AX; Osman M; Gniadecki R
Dermatology; 2020; 236(2):105-110. PubMed ID: 31362294
[TBL] [Abstract][Full Text] [Related]
16. Current treatment options in systemic Sclerosis (Scleroderma).
Stummvoll GH
Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Treatment of Systemic Sclerosis and Morphea.
Teske N; Fett N
Am J Clin Dermatol; 2024 Mar; 25(2):213-226. PubMed ID: 38087156
[TBL] [Abstract][Full Text] [Related]
18. Assessment of kidney involvement in systemic sclerosis: From scleroderma renal crisis to subclinical renal vasculopathy.
Gigante A; Leodori G; Pellicano C; Villa A; Rosato E
Am J Med Sci; 2022 Nov; 364(5):529-537. PubMed ID: 35537505
[TBL] [Abstract][Full Text] [Related]
19. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
20. Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis.
Abraham D; Lescoat A; Stratton R
Mol Aspects Med; 2024 Apr; 96():101252. PubMed ID: 38325132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]